Legal Opinion
Chiron Corp. v. Genentech, Inc.
District Court, E.D. California
Decided June 24, 2002No. CIV.S-00-1252 WBS GGPublishedCited by 3 opinions
1Opinion of the Court
MEMORANDUM AND ORDER RE: PRIORITY, ANTICIPATION, WRITTEN DESCRIPTION, EN-ABLEMENT, BEST MODE, UTILITY
SHUBB, District Judge.
In a separate order, the court has determined that Genentech’s product, Hercep-tin, infringes Chiron’s U.S. Patent No. 6,054,561 (“ ’561 patent”). Chiron and Genentech now bring cross motions for summary judgment on Genentech’s anticipation, written description and enablement defenses under 35 U.S.C. §§ 102, 112. These cross motions address the central question of whether the ’561 patent is entitled to the benefit of the 1984, 1985, and/or 1986 filing dates of three…
2Cases cited40 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Taylor v. ListCourt of Appeals for the Ninth Circuit · 1989
- Hybritech Incorporated v. Monoclonal Antibodies, Inc.Court of Appeals for the Federal Circuit · 1986
35 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- ABS Global, Inc. v. Inguran, LLCCourt of Appeals for the Seventh Circuit · 2019
- B-K Lighting, Inc. v. Vision3 LightingDistrict Court, C.D. California · 2013
- Honeywell International Inc. v. United StatesUnited States Court of Federal Claims · 2008